Australian Clinical Labs Ltd. logo

Australian Clinical Labs Ltd. (ACL)

Market Open
ASX ASX
716.69M Market Cap
- P/E Ratio
0% Div Yield
241,048 Volume
- Eps
Want to track ACL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 43 days
Australian Clinical Labs Ltd. logo
ACL Australian Clinical Labs Ltd.
27 Mar 2025
A$0.04 Dividend
16 Apr 2025 Payment Date
- Record Date
- Declaration Date
Australian Clinical Labs Ltd. logo
ACL Australian Clinical Labs Ltd.
4 Sep 2024
A$0.09 Dividend
27 Sep 2024 Payment Date
- Record Date
- Declaration Date
Australian Clinical Labs Ltd. logo
ACL Australian Clinical Labs Ltd.
28 Mar 2024
A$0.03 Dividend
26 Apr 2024 Payment Date
- Record Date
- Declaration Date
Australian Clinical Labs Ltd. logo
ACL Australian Clinical Labs Ltd.
14 Sep 2023
A$0.07 Dividend
3 Oct 2023 Payment Date
- Record Date
- Declaration Date
Australian Clinical Labs Ltd. logo
ACL Australian Clinical Labs Ltd.
27 Mar 2023
A$0.07 Dividend
26 Apr 2023 Payment Date
- Record Date
- Declaration Date
Australian Clinical Labs Ltd. logo
ACL Australian Clinical Labs Ltd.
23 Aug 2022
A$0.41 Dividend
15 Sep 2022 Payment Date
- Record Date
- Declaration Date
Australian Clinical Labs Ltd. logo
ACL Australian Clinical Labs Ltd.
25 Mar 2022
A$0.12 Dividend
21 Apr 2022 Payment Date
- Record Date
- Declaration Date

ACL Dividend FAQ

What is the dividend yield?

The current dividend yield for ACL is 0%, based on the most recent dividend payment and the current stock price of A$2.76 on the ASX.

How often are dividends paid?

Dividends are paid on a FINAL basis, with typical payment being Varies.

What is the dividend history?

The company has a dividend payment history that includes 3 years of consistent payments. The most recent payment was A$0.04 per share on 2025-03-27. For related earnings insights, visit the ACL Earnings page.

What is the average annual dividend growth rate?

The average annual dividend growth rate over the past 3 years is approximately -33.68%, reflecting the ACL's commitment to rewarding shareholders.